4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-20-018812
President sold 25,000 shares at $90.00 ($2,250,000)
- President acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Novak Rodger President | 2020-07-07 | Option exercise | +5,586 | $1.81 | $10,111 | 653,593 | D |
| Novak Rodger President | 2020-07-07 | Option exercise | +19,414 | $14.00 | $271,796 | 673,007 | D |
| Novak Rodger President | 2020-07-07 | Sale | −25,000 | $90.00 | $2,250,000 | 648,007 | D |
| Derivatives | |||||||
| Novak Rodger President | 2020-07-07 | Option exercise · Stock Option (Right to Buy) | −5,586 | 0 | D | ||
| Novak Rodger President | 2020-07-07 | Option exercise · Stock Option (Right to Buy) | −19,414 | 140,826 | D | ||
| Open-market sales · 25,000 sh · avg $90.00 · $2,250,000 | |||||||
Loading xslF345X03/doc4.xml…